Warren D. Reynolds

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas

Robbie G. Majzner, Sneha Ramakrishna, Kristen W. Yeom et al. · Nature · 2022 · 737 citations · Full text

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

Zinaida Good, Jay Y. Spiegel, Bita Sahaf et al. · Nature Medicine · 2022 · 224 citations · Full text

Cell Therapy, Cellular Therapies, T-regulatory Cell +10

Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

Michelle Monje, Jasia Mahdi, Robbie G. Majzner et al. · Nature · 2024 · 123 citations · Full text

CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

John H. Baird, Matthew J. Frank, Juliana Craig et al. · Blood · 2020 · 80 citations · Full text